Carl Zeiss Meditec, Inc.

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker	Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, brain cancer, brain disorder, central nervous system cancer, central nervous system disorder, epithelial neoplasm, glioma, neoplasm, nervous system disorder, neuroepithelial neoplasm, primitive neuroectodermal tumor	Active, not recruiting	Phase 2	2026-07-29		NCT02691923
Evaluation of the CONVIVO System	Brain Metastases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pituitary Neoplasms, astrocytoma (excluding glioblastoma), brain disorder, central nervous system cancer, central nervous system disorder, endocrine system disorder, epithelial neoplasm, glioblastoma, glioma, hypothalamic disorder, hypothalamic neoplasm, malignant endocrine neoplasm, meningioma, neoplasm, nerve sheath neoplasm, nervous system disorder, neuroendocrine neoplasm, neuroepithelial neoplasm, neuroma, pituitary gland disorder, primitive neuroectodermal tumor, schwannoma, supratentorial cancer, tumor of meninges, vascular cancer	Recruiting	Not applicable	2026-02-06		NCT05139277

Clinical trials